
TY  - JOUR
TI  - 2000 Annual Meeting Abstracts
JO  - Journal of Periodontology
JA  - Journal of Periodontology
VL  - 71
IS  - 12
SN  - 0022-3492
UR  - https://doi.org/10.1902/jop.2000.71.12.1910
DO  - doi:10.1902/jop.2000.71.12.1910
SP  - 1910
EP  - 1927
PY  - 2000
ER  - 

TY  - JOUR
AU  - Pereira, Talita Carneiro Brandão
AU  - Campos, Maria Martha
AU  - Bogo, Maurício Reis
C8  - JAT-15-0705.R1
TI  - Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model
JO  - Journal of Applied Toxicology
JA  - J. Appl. Toxicol.
VL  - 36
IS  - 7
SN  - 0260-437X
UR  - https://doi.org/10.1002/jat.3303
DO  - doi:10.1002/jat.3303
SP  - 876
EP  - 885
KW  - copper
KW  - oxidative stress
KW  - inflammation
KW  - zebrafish
KW  - ChIn assay
KW  - copper-induced inflammation
PY  - 2016
AB  - Abstract Copper is an essential micronutrient and a key catalytic cofactor in a wide range of enzymes. As a trace element, copper levels are tightly regulated and both its deficit and excess are deleterious to the organism. Under inflammatory conditions, serum copper levels are increased and trigger oxidative stress responses that activate inflammatory responses. Interestingly, copper dyshomeostasis, oxidative stress and inflammation are commonly present in several chronic diseases. Copper exposure can be easily modeled in zebrafish; a consolidated model in toxicology with increasing interest in immunity-related research. As a result of developmental, economical and genetic advantages, this freshwater teleost is uniquely suitable for chemical and genetic large-scale screenings, representing a powerful experimental tool for a whole-organism approach, mechanistic studies, disease modeling and beyond. Copper toxicological and more recently pro-inflammatory effects have been investigated in both larval and adult zebrafish with breakthrough findings. Here, we provide an overview of copper metabolism in health and disease and its effects on oxidative stress and inflammation responses in zebrafish models. Copper-induced inflammation is highlighted owing to its potential to easily mimic pro-oxidative and pro-inflammatory features that combined with zebrafish genetic tractability could help further in the understanding of copper metabolism, inflammatory responses and related diseases. Copyright ? 2016 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
AU  - Samanta, R.
AU  - Shoukrey, K.
AU  - Griffiths, R.
TI  - Rheumatoid arthritis and anaesthesia
JO  - Anaesthesia
VL  - 66
IS  - 12
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.2011.06890.x
DO  - doi:10.1111/j.1365-2044.2011.06890.x
SP  - 1146
EP  - 1159
PY  - 2011
AB  - Summary There has been a great deal of progress in our understanding and management of rheumatoid arthritis in recent years. The peri-operative management of rheumatoid arthritis patients can be challenging and anaesthetists need to be familiar with recent developments and potential risks of this multi system disease. You can respond to this article at http://www.anaesthesiacorrespondence.com
ER  - 

TY  - JOUR
AU  - Fasth, Anders
AU  - Porras, Oscar
TI  - Human malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantation
JO  - Pediatric Transplantation
VL  - 3
IS  - s1
SN  - 1397-3142
UR  - https://doi.org/10.1034/j.1399-3046.1999.00063.x
DO  - doi:10.1034/j.1399-3046.1999.00063.x
SP  - 102
EP  - 107
KW  - osteopetrosis
KW  - bone marrow transplantation
KW  - osteoclasts
PY  - 1999
AB  - Abstract: steopetrosis is a heterogeneous group of diseases characterized by lack of osteoclast function. Osteopetrosis is found spontaneously in most mammalian species and many transgenic animals have been created, but so far no animal model has been found that genetically corresponds to human malignant autosomal recessive osteopetrosis. The only curative treatment for malignant osteopetrosis is bone marrow transplantation. A review of the literature and preliminary data from IBMTR shows that infants transplanted with marrow from an HLA-identical sibling or unrelated volunteer donor have an actuarian five-year survival with a functioning graft of 50?70%, while those transplanted with a T-cell-depleted mismatched marrow have a very poor survival of only about 10%.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
VL  - 135
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/j.1365-2567.2011.03534.x
DO  - doi:10.1111/j.1365-2567.2011.03534.x
SP  - 52
EP  - 212
PY  - 2011
ER  - 

TY  - JOUR
TI  - Eighteenth UICC International Cancer Conference June 30–July 5, 2002
JO  - International Journal of Cancer
JA  - Int. J. Cancer
VL  - 100
IS  - S13
SN  - 0020-7136
UR  - https://doi.org/10.1002/ijc.9986
DO  - doi:10.1002/ijc.9986
SP  - 464
EP  - 489
PY  - 2002
ER  - 

TY  - JOUR
TI  - Tobacco & Related Substances SIG: Oral Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_13.x
DO  - doi:10.1111/j.1440-1843.2011.01936_13.x
SP  - 24
EP  - 24
PY  - 2011
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG: Oral Session 2
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_14.x
DO  - doi:10.1111/j.1440-1843.2011.01936_14.x
SP  - 24
EP  - 26
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oeld/Population Health SIG: Oral Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_17.x
DO  - doi:10.1111/j.1440-1843.2011.01936_17.x
SP  - 28
EP  - 30
PY  - 2011
ER  - 

TY  - JOUR
TI  - Pulmonary Physiology & Sleep SIG: Oral Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_18.x
DO  - doi:10.1111/j.1440-1843.2011.01936_18.x
SP  - 30
EP  - 31
PY  - 2011
ER  - 

TY  - JOUR
TI  - Respiratory Nurses SIG: Oral Session 2
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_2.x
DO  - doi:10.1111/j.1440-1843.2011.01936_2.x
SP  - 9
EP  - 10
PY  - 2011
ER  - 

TY  - JOUR
TI  - Cell Biology/Immunology SIG: Oral Session 2
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_7.x
DO  - doi:10.1111/j.1440-1843.2011.01936_7.x
SP  - 15
EP  - 16
PY  - 2011
ER  - 

TY  - JOUR
AU  - Sakaguchi, Shimon
TI  - Regulatory T cells in the past and for the future
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 38
IS  - 4
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200890012
DO  - doi:10.1002/eji.200890012
SP  - 901
EP  - 937
PY  - 2008
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
AU  - Erlandsson Harris, Helena
AU  - Andersson, Ulf
TI  - Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 34
IS  - 6
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200424916
DO  - doi:10.1002/eji.200424916
SP  - 1503
EP  - 1512
KW  - HMGB1
KW  - Nuclear protein
KW  - Inflammation
KW  - Necrosis
PY  - 2004
AB  - Abstract The intranuclear architectural protein that is termed high mobility group box chromosomal protein 1 (HMGB1) was recently identified as a potent proinflammatory mediator when present extracellularly. HMGB1 has been demonstrated to be a long-searched-for nuclear danger signal passively released by necrotic, as opposed to apoptotic, cells that will induce inflammation. Furthermore, HMGB1 can also be actively secreted by stimulated macrophages or monocytes in a process requiring acetylation of the molecule, which enables translocation from the nucleus to secretory lysosomes. Subsequenttransport out of the cells depends on a secretion signal mediated by either extracellular lysophophatidyl-choline or ATP. HMGB1 passively released from necrotic cells and HMGB1 actively secreted byinflammatory cells are thus molecularly different. Extracellular HMGB1 acts as a cytokine by signaling via the receptor for advanced glycated end-products and via members of the Toll-like receptor family. The initiated inflammatory responses include the production of multiple cytokines, chemoattraction of certain stem cells, induction of vascular adhesion molecules and impaired function of intestinalepithelial cells. Therapeutic administration of HMGB1 antagonists rescues mice from lethal sepsis, even when initial treatment is delayed for 24?h after the onset of infection, establishing a clinically relevant therapeutic window that is significantly wider than for other known cytokines.
ER  - 

TY  - JOUR
TI  - Paediatric SIG/Asthma & Allergy SIG: Joint Oral Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_11.x
DO  - doi:10.1111/j.1440-1843.2011.01936_11.x
SP  - 21
EP  - 22
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oliv SIG: Oral Session 1
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_6.x
DO  - doi:10.1111/j.1440-1843.2011.01936_6.x
SP  - 14
EP  - 15
PY  - 2011
ER  - 

TY  - JOUR
TI  - COPD SIG: Oral Session 2
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_15.x
DO  - doi:10.1111/j.1440-1843.2011.01936_15.x
SP  - 26
EP  - 27
PY  - 2011
ER  - 

TY  - JOUR
TI  - Paediatric SIG: Oral Session
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_20.x
DO  - doi:10.1111/j.1440-1843.2011.01936_20.x
SP  - 32
EP  - 33
PY  - 2011
ER  - 

TY  - JOUR
TI  - COPD SIG: Oral Session 1
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_5.x
DO  - doi:10.1111/j.1440-1843.2011.01936_5.x
SP  - 12
EP  - 14
PY  - 2011
ER  - 

TY  - JOUR
TI  - Asthma & Allergy SIG: Oral Session 1
JO  - Respirology
VL  - 16
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2011.01936_9.x
DO  - doi:10.1111/j.1440-1843.2011.01936_9.x
SP  - 18
EP  - 19
PY  - 2011
ER  - 
